$0.9081
-0.10-10.09%
Last update: Nov 6, 4:24 AM
NovaBridge Biosciences (NBP) Stock Price, Quote, News & History
NBPNASDAQ
NovaBridge stock jumps after VIS-101 Phase 2a study shows strong vision improvement in wet age-related macular degeneration patients.
You can purchase shares of NovaBridge Biosciences (NASDAQ:NBP) through any online brokerage.
Other companies in NovaBridge Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
NovaBridge Biosciences has a consensus price target of $9.00.
The stock price for NovaBridge Biosciences (NASDAQ: NBP) is $0.91 last updated November 6, 2026 at 4:24 AM EST.
There are no upcoming dividends for NovaBridge Biosciences.
NovaBridge Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for NovaBridge Biosciences.
NovaBridge Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs,...
